Podcast Episode 2: Trials Beyond Borders

Podcast

Episode 2 of the Trials Beyond Borders podcast is now available on all streaming platforms. In this episode, Racquel Bruton, Associate Director and Clinical Trials Diversity Portfolio Lead at Biogen, and Willyanne DeCormier Plosky, Program Director at the MRCT Center, discuss how sponsor companies are enhancing representation in clinical trials, particularly outside the US. Racquel highlights Biogen’s longstanding commitment to reaching underrepresented populations and explores how the MRCT Center’s roadmap can help organizations develop effective diversity action plans. Tune in to learn practical insights on operationalizing diversity strategies.

Podcast Episode 1: Trials Beyond Borders

Podcast

Presented on: August 28, 2024

The first podcast in our new series, “Trials Beyond Borders: Building Representative Clinical Trials Worldwide.” The podcast features a conversation with MRCT Center Program Director Willyanne DeCormier Plosky and Tinaya Gray, a consultant with ICON plc, focusing on communications between sponsors, CROs, and sites in planning for diversity action plans in the context of global trials.  

Related Resources

Global Representation
Model Diversity Action Plan (DAP)
Global GDEI Roadmap

Drug Researchers Refuse To Follow The Law. The Government Isn’t Stopping Them

Podcast

Broadcast on: January 24, 2020

Podcast: Science Friday

Before any new drug comes to market, it goes through a time-consuming process. Researchers have to recruit human subjects for a clinical trial, collect all the data, and analyze the results. All of that can take years to complete, but the end result could be worth it: a drug that treats a rare disease or improves patients lives with fewer side effects.

SciFri · Drug Researchers Refuse To Follow The Law. The Government Is Not Stopping Them.